Compare CYTK & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | BIRK |
|---|---|---|
| Founded | 1997 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.0B |
| IPO Year | 2004 | 2023 |
| Metric | CYTK | BIRK |
|---|---|---|
| Price | $60.52 | $38.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 14 |
| Target Price | ★ $87.56 | $62.69 |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,368,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $302.66 | $14.21 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.31 | $35.70 |
| 52 Week High | $70.98 | $57.39 |
| Indicator | CYTK | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 45.71 |
| Support Level | $59.25 | $37.73 |
| Resistance Level | $65.93 | $42.19 |
| Average True Range (ATR) | 2.76 | 1.64 |
| MACD | -0.35 | -0.32 |
| Stochastic Oscillator | 18.21 | 35.75 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.